Literature DB >> 33520711

Progression-Mediated Changes in Mitochondrial Morphology Promotes Adaptation to Hypoxic Peritoneal Conditions in Serous Ovarian Cancer.

Joseph P Grieco1, Mitchell E Allen2, Justin B Perry2, Yao Wang2, Yipei Song3, Ali Rohani3, Stephanie L E Compton2, James W Smyth4,5,6, Nathan S Swami3, David A Brown2, Eva M Schmelz2.   

Abstract

Ovarian cancer is the deadliest gynecological cancer in women, with a survival rate of less than 30% when the cancer has spread throughout the peritoneal cavity. Aggregation of cancer cells increases their viability and metastatic potential; however, there are limited studies that correlate these functional changes to specific phenotypic alterations. In this study, we investigated changes in mitochondrial morphology and dynamics during malignant transition using our MOSE cell model for progressive serous ovarian cancer. Mitochondrial morphology was changed with increasing malignancy from a filamentous network to single, enlarged organelles due to an imbalance of mitochondrial dynamic proteins (fusion: MFN1/OPA1, fission: DRP1/FIS1). These phenotypic alterations aided the adaptation to hypoxia through the promotion of autophagy and were accompanied by changes in the mitochondrial ultrastructure, mitochondrial membrane potential, and the regulation of reactive oxygen species (ROS) levels. The tumor-initiating cells increased mitochondrial fragmentation after aggregation and exposure to hypoxia that correlated well with our previously observed reduced growth and respiration in spheroids, suggesting that these alterations promote viability in non-permissive conditions. Our identification of such mitochondrial phenotypic changes in malignancy provides a model in which to identify targets for interventions aimed at suppressing metastases.
Copyright © 2021 Grieco, Allen, Perry, Wang, Song, Rohani, Compton, Smyth, Swami, Brown and Schmelz.

Entities:  

Keywords:  fission; fragmentation; fusion; hypoxia; mitophagy; reactive oxygen species; spheroids; uncoupling protein

Year:  2021        PMID: 33520711      PMCID: PMC7838066          DOI: 10.3389/fonc.2020.600113

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  8 in total

1.  Siah2-GRP78 interaction regulates ROS and provides a proliferative advantage to Helicobacter pylori-infected gastric epithelial cancer cells.

Authors:  Pragyesh Dixit; Swathi Shivaram Suratkal; Shrikant Babanrao Kokate; Debashish Chakraborty; Indrajit Poirah; Supriya Samal; Niranjan Rout; Shivaram P Singh; Arup Sarkar; Asima Bhattacharyya
Journal:  Cell Mol Life Sci       Date:  2022-07-11       Impact factor: 9.207

2.  Select Per- and Polyfluoroalkyl Substances (PFAS) Induce Resistance to Carboplatin in Ovarian Cancer Cell Lines.

Authors:  Brittany P Rickard; Xianming Tan; Suzanne E Fenton; Imran Rizvi
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

3.  Quantitative biophysical metrics for rapid evaluation of ovarian cancer metastatic potential.

Authors:  Apratim Mukherjee; Haonan Zhang; Katherine Ladner; Megan Brown; Jacob Urbanski; Joseph P Grieco; Rakesh K Kapania; Emil Lou; Bahareh Behkam; Eva M Schmelz; Amrinder S Nain
Journal:  Mol Biol Cell       Date:  2022-01-05       Impact factor: 3.612

4.  Melatonin Reverses the Warburg-Type Metabolism and Reduces Mitochondrial Membrane Potential of Ovarian Cancer Cells Independent of MT1 Receptor Activation.

Authors:  Maira Smaniotto Cucielo; Roberta Carvalho Cesário; Henrique Spaulonci Silveira; Letícia Barbosa Gaiotte; Sérgio Alexandre Alcantara Dos Santos; Debora Aparecida Pires de Campos Zuccari; Fábio Rodrigues Ferreira Seiva; Russel J Reiter; Luiz Gustavo de Almeida Chuffa
Journal:  Molecules       Date:  2022-07-07       Impact factor: 4.927

Review 5.  The Interplay between Dysregulated Ion Transport and Mitochondrial Architecture as a Dangerous Liaison in Cancer.

Authors:  Stine F Pedersen; Mette Flinck; Luis A Pardo
Journal:  Int J Mol Sci       Date:  2021-05-14       Impact factor: 5.923

Review 6.  Role of Mitochondria in Interplay between NGF/TRKA, miR-145 and Possible Therapeutic Strategies for Epithelial Ovarian Cancer.

Authors:  Daniela B Vera; Allison N Fredes; Maritza P Garrido; Carmen Romero
Journal:  Life (Basel)       Date:  2021-12-21

Review 7.  Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations.

Authors:  Amy H Lee; Carolina Mejia Peña; Michelle R Dawson
Journal:  Cancers (Basel)       Date:  2022-03-10       Impact factor: 6.639

8.  Metabolic Reprogramming of Ovarian Cancer Spheroids during Adhesion.

Authors:  Stephanie L E Compton; Joseph P Grieco; Benita Gollamudi; Eric Bae; Jennifer H Van Mullekom; Eva M Schmelz
Journal:  Cancers (Basel)       Date:  2022-03-09       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.